Literature DB >> 16242851

Major depression is not a diagnosis, it is a departure point to differential diagnosis -- clinical and hormonal considerations (a commentary and elaboration on Antonejevic's paper).

Uriel Halbreich1.   

Abstract

Currently, the prevailing diagnostic systems of mental disorders, including Depressions and anxieties are based on descriptive phenomenological approach and not on etiology and pathophysiology. However, cumulative knowledge suggests that the field is moving towards establishment of subtypes or phenotypes of depressions based on different pathophysiologies, which may result in differential treatment responses. What is currently defined as 'Major Depressive Disorder (MDD)' may be the end-result of multiple heterogeneous biological and psychosocial processes. Therefore, MDD is actually a first step towards a differential diagnosis that eventually may lead to pathophysiology-based entities. Several hormonal systems may play a major role in the pathophysiology of several subtypes of depressions and anxieties. They include but are not limited to dysregulation of the hypothalamic-pituitary-adrenal (HPA) system, HP-Gonadal (HPG) and Thyroid (HPT) systems as well as their interactions with immune and other biological and psychosocial processes. Elucidation of the multiple underlying mechanisms of depressions and anxieties should lead to targeted treatment modalities and improvement of treatment responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16242851     DOI: 10.1016/j.psyneuen.2005.08.004

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  6 in total

1.  Depressive symptom composites associated with cortisol stress reactivity in adolescents.

Authors:  Matthew C Morris; Chrystyna D Kouros; Alyssa S Mielock; Uma Rao
Journal:  J Affect Disord       Date:  2016-12-20       Impact factor: 4.839

2.  SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model.

Authors:  M E Breuer; M M van Gaalen; W Wernet; S E F Claessens; R S Oosting; B Behl; S M Korte; H Schoemaker; G Gross; B Olivier; L Groenink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-31       Impact factor: 3.000

3.  Sex-specific modulation of gene expression networks in murine hypothalamus.

Authors:  Khyobeni Mozhui; Lu Lu; William E Armstrong; Robert W Williams
Journal:  Front Neurosci       Date:  2012-05-11       Impact factor: 4.677

4.  Behavioural screening of zebrafish using neuroactive traditional Chinese medicine prescriptions and biological targets.

Authors:  Ya-Nan Wang; Yuan-Yuan Hou; Ming-Zhu Sun; Chun-Yang Zhang; Gang Bai; Xin Zhao; Xi-Zeng Feng
Journal:  Sci Rep       Date:  2014-06-16       Impact factor: 4.379

5.  Metabolomic biosignature differentiates melancholic depressive patients from healthy controls.

Authors:  Yashu Liu; Lynn Yieh; Tao Yang; Wilhelmus Drinkenburg; Pieter Peeters; Thomas Steckler; Vaibhav A Narayan; Gayle Wittenberg; Jieping Ye
Journal:  BMC Genomics       Date:  2016-08-23       Impact factor: 3.969

6.  Latent Class Analysis in Depression, Including Clinical and Functional Variables: Evidence of a Complex Depressive Subtype in Primary Care in Chile.

Authors:  Verónica Vitriol; Alfredo Cancino; Carlos Serrano; Soledad Ballesteros; Marcela Ormazábal; Marcelo Leiva-Bianchi; Carolina Salgado; Cristian Cáceres; Soledad Potthoff; Francisca Orellana; Andrea Asenjo
Journal:  Depress Res Treat       Date:  2021-02-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.